CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
CAS No. 254110-79-7
CEF27,Epstein-Barr Virus BRLF-1 lytic 148-156( —— )
Catalog No. M29966 CAS No. 254110-79-7
HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameCEF27,Epstein-Barr Virus BRLF-1 lytic 148-156
-
NoteResearch use only, not for human use.
-
Brief DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
-
DescriptionHLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).(In Vitro):Expression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In VitroExpression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number254110-79-7
-
Formula Weight302.93
-
Molecular FormulaTKSVY2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Arg}{Val}{Arg}{Ala}{Tyr}{Thr}{Tyr}{Ser}{Lys}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Darr CD, et al. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001 Jul;75(13):6135-42.
molnova catalog
related products
-
Tolycaine
Tolycaine is a compound of local anesthetic.
-
Ganoderic acid X
Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells.
-
1,5,5-Trimethylhydan...
1,5,5-Trimethylhydantoin (TMH) is a non-isotopic internal standard (IS).